Michael Zinda, EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc. (RPTX), sold 860 shares at $4.66 ($4K) on 2024-04-01, disclosed to the SEC on 2024-04-01.
Scheduled sale ($4k) by EVP, CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.64 | 450 | $2K | 52.2% |
| 2 | $4.66 | 410 | $2K | 47.8% |
| Total | $4.65 avg | 860 | $4K | 100% |
| Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |
| RPTX | SELL | 2022-03-16 | $6K | — | Filing → |